Showing 20 of 52 recruiting trials for “primary-localized-amyloidosis”
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
👨⚕️ Mirella Calcinai, MD, Medical Director, Clinical Development📍 3 sites📅 Started Feb 2026View details ↗
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
🏥 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.📍 23 sites📅 Started Dec 2025View details ↗
RecruitingNCT07448935 ↗
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
RecruitingNCT07448779 ↗
Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
Teclistamab-Daratumumab in AL Amyloidosis
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
RecruitingNCT07172243 ↗
BE.Amycon Biobank & Data Registry UZ Leuven
Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
👨⚕️ Sara Alehashemi, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2025View details ↗
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
RecruitingNCT07232459 ↗
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Teclistamab in Previously Treated AL Amyloidosis
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
RecruitingNCT06354322 ↗
Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →